Nvidias Earnings Reveal a 200 Billion Opportunity and Edge Computing Push Despite China Concession Paytm Block Deal Societe Generale Ghisallo Viridian Lead Buyers in Rs 964 Crore Stake Sale USChina Trade Rifts Persist at APEC After TrumpXi Summit Microns AI Memory Demand Surge CEO Highlights 5066 Supply Gap as HBM Pricing Soars Ethereums Path Beyond 4000 Market Factors and Sentiment SNC Scandic Coin Enters Market as Regulated RealWorld Asset Project on Multiple Exchanges Summit Hotel Properties Q1 2026 Earnings Narrower Loss Beats Estimates Shares Edge Higher Marine Products Corporation MPX Q1 2026 Earnings Weak Profitability and Stock Decline Highlight Ongoing Challenges DMC Global Q1 2026 Earnings Narrowing Losses as EPS Surprises to the Upside MFIC Q1 2026 Earnings EPS Beats Estimates Stock Dips SXTP Q1 2026 Earnings Significant EPS Miss as Company Continues PreRevenue Phase AAT Q1 2026 Earnings EPS Misses Estimates but Stock Gains 364 BuildABear Workshop BBW Holds Near Support as Market Gauges Retail Sentiment Titan America TTAM Holds Steady Near Support Resistance Awaits Bon Natural Life Limited BON Holds Steady at 127 Amid Low Volatility Suncor Energy SU Retreats 243 as Selling Pressure Builds Toward Support Perdoceo Education PRDO Maintains Stability Near 34 Amid Modest Gains Westwater Resources Inc WWR Q1 2026 Earnings Narrow Loss Beats Estimates as Stock Surges 25 Banner Corporation BANR Q1 2026 Earnings Earnings Beat Expectations on Strong Operating Performance Atlanta Braves Holdings Inc Series A BATRA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid OffSeason Airship AI Holdings Q3 2025 Earnings EPS Falls Sharply Short of Estimates as Stock Rallies LEDS Q1 2026 Earnings Narrowed Loss Per Share Drives DoubleDigit Stock Rally BBB Foods Inc TBBB Q1 2026 Earnings EPS Misses Estimates Stock Rises on Operational Progress US GDP Growth Revised Down to 16 in First Quarter Underscoring Economic Slowdown AFB Q3 2024 Earnings Net Investment Income per Share Reported at 011 No Analyst Estimate Available Ernexa Therapeutics ERNA Slips 38 as Shares Test Key Support Near 1139